SomnoMed 관리
관리 기준 확인 2/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Amrita Blickstead
최고 경영자
AU$624.3k
총 보상
CEO 급여 비율 | 26.7% |
CEO 임기 | 4.3yrs |
CEO 소유권 | 0.5% |
경영진 평균 재임 기간 | 5.3yrs |
이사회 평균 재임 기간 | 4.3yrs |
최근 관리 업데이트
Recent updates
Benign Growth For SomnoMed Limited (ASX:SOM) Underpins Stock's 27% Plummet
Oct 16SomnoMed Limited's (ASX:SOM) Share Price Boosted 30% But Its Business Prospects Need A Lift Too
Jul 15SomnoMed Limited (ASX:SOM) Shares Fly 30% But Investors Aren't Buying For Growth
May 31SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 15SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Mar 04Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)
Dec 21SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks
Sep 02Is SomnoMed (ASX:SOM) Using Too Much Debt?
Jun 19It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year
Nov 18SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Sep 27Is SomnoMed (ASX:SOM) Using Debt Sensibly?
May 10Is SomnoMed (ASX:SOM) Using Debt Sensibly?
Oct 26Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?
May 12Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?
Mar 02Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?
Feb 01Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?
Dec 28Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?
Dec 01Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)
Jul 28SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings
Jul 14CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Jun 30 2024 | AU$624k | AU$167k | -AU$12m |
Mar 31 2024 | n/a | n/a | -AU$11m |
Dec 31 2023 | n/a | n/a | -AU$11m |
Sep 30 2023 | n/a | n/a | -AU$9m |
Jun 30 2023 | AU$91k | n/a | -AU$8m |
Mar 31 2023 | n/a | n/a | -AU$7m |
Dec 31 2022 | n/a | n/a | -AU$5m |
Sep 30 2022 | n/a | n/a | -AU$5m |
Jun 30 2022 | AU$91k | n/a | -AU$4m |
Mar 31 2022 | n/a | n/a | -AU$5m |
Dec 31 2021 | n/a | n/a | -AU$5m |
Sep 30 2021 | n/a | n/a | -AU$3m |
Jun 30 2021 | AU$32k | n/a | -AU$1m |
보상 대 시장: Amrita 의 총 보상 ($USD 406.67K )은 Australian 시장( $USD 298.55K ).
보상과 수익: 회사가 수익성이 없는 동안 Amrita 의 보상이 증가했습니다.
CEO
Amrita Blickstead
4.3yrs
테뉴어
AU$624,323
보상
Ms. Amrita Blickstead, MBA, BME, is Co-Chief Executive Officer and Executive Director of SomnoMed Limited. Ms. Blickstead was Non-Executive Director of SomnoMed Limited from August 24, 2020. Ms. Blickstead...
리더십 팀
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Co-CEO & Executive Director | no data | AU$624.32k | 0.49% A$ 261.5k | |
Co-CEO & Executive Director | no data | AU$693.50k | 0.24% A$ 125.9k | |
Vice President of Global Marketing | 5.3yrs | AU$483.37k | 0.067% A$ 35.4k | |
Executive VP of Sales & Marketing - North America | 5.1yrs | AU$427.31k | 데이터 없음 | |
Vice President of Marketing & Sales - Europe | no data | AU$589.17k | 데이터 없음 | |
Company Secretary | 29.8yrs | AU$10.56k | 데이터 없음 | |
Vice President of Global Production and Product Development | no data | AU$159.55k | 데이터 없음 |
5.3yrs
평균 재임 기간
경험이 풍부한 관리: SOM 의 관리팀은 노련하고 경험 (평균 재직 기간 5.3 년)입니다.
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Co-CEO & Executive Director | 4.3yrs | AU$624.32k | 0.49% A$ 261.5k | |
Co-CEO & Executive Director | 4yrs | AU$693.50k | 0.24% A$ 125.9k | |
Non-Executive Director | 4.3yrs | AU$92.38k | 0.10% A$ 55.1k | |
Member of the Medical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Member of the Medical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Chairman of the Medical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Chairman of the Board | 4.3yrs | AU$160.96k | 0.64% A$ 340.6k | |
Non-Executive Director | less than a year | 데이터 없음 | 데이터 없음 |
4.3yrs
평균 재임 기간
58yo
평균 연령
경험이 풍부한 이사회: SOM 의 이사회는 경험(평균 재직 기간 4.3 년)으로 간주됩니다.